Search research articles
Contact Us
Filters
Showing results (61-70 of 93) with videos related to
Page
of 10
Sort By:
European Journal of Haematology
|
May 29, 2015
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia
Maria Teresa Voso, Pasquale Niscola, Alfonso Piciocchi, et al.
Cancers
|
October 14, 2022
Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience
Matteo Molica, Carla Mazzone, Pasquale Niscola, et al.
Mycoses
|
July 23, 2020
Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study)
Anna Candoni, Francesca Farina, Katia Perruccio, et al.
Leukemia
|
February 23, 2020
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index
Fabio Efficace, Francesco Cottone, Laura B Oswald, et al.
Journal of Clinical Medicine
|
May 14, 2022
Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical-Biological Entity?
Alessia Campagna, Daniela De Benedittis, Luana Fianchi, et al.
Haematologica
|
August 4, 2006
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study
Livio Pagano, Morena Caira, Anna Candoni, et al.
Cancer
|
December 13, 2017
Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes
Fabio Efficace, Francesco Cottone, Gregory Abel, et al.
Hematological Oncology
|
January 1, 2020
Pulmonary infections in patients with myelodysplastic syndromes receiving frontline azacytidine treatment
Roberto Latagliata, Pasquale Niscola, Luana Fianchi, et al.
Cancers
|
April 27, 2024
Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review
Marianna Criscuolo, Maria Elena Tosti, Alessandro Broccoli, et al.
International Journal of Hematology
|
November 27, 2008
Advanced mast cell disease: an Italian Hematological Multicenter experience
Livio Pagano, Caterina Giovanna Valentini, Morena Caira, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 93) with videos related to
Sort By:
Page
of 10
European Journal of Haematology
|
May 29, 2015
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia
Maria Teresa Voso, Pasquale Niscola, Alfonso Piciocchi, et al.
Cancers
|
October 14, 2022
Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience
Matteo Molica, Carla Mazzone, Pasquale Niscola, et al.
Mycoses
|
July 23, 2020
Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study)
Anna Candoni, Francesca Farina, Katia Perruccio, et al.
Leukemia
|
February 23, 2020
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index
Fabio Efficace, Francesco Cottone, Laura B Oswald, et al.
Journal of Clinical Medicine
|
May 14, 2022
Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical-Biological Entity?
Alessia Campagna, Daniela De Benedittis, Luana Fianchi, et al.
Haematologica
|
August 4, 2006
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study
Livio Pagano, Morena Caira, Anna Candoni, et al.
Cancer
|
December 13, 2017
Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes
Fabio Efficace, Francesco Cottone, Gregory Abel, et al.
Hematological Oncology
|
January 1, 2020
Pulmonary infections in patients with myelodysplastic syndromes receiving frontline azacytidine treatment
Roberto Latagliata, Pasquale Niscola, Luana Fianchi, et al.
Cancers
|
April 27, 2024
Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review
Marianna Criscuolo, Maria Elena Tosti, Alessandro Broccoli, et al.
International Journal of Hematology
|
November 27, 2008
Advanced mast cell disease: an Italian Hematological Multicenter experience
Livio Pagano, Caterina Giovanna Valentini, Morena Caira, et al.
Page
of 10